June 5, 2008 — A case study concerning the Axiom Worldwide’s DRX9000, published in the 2008 issue of the European Musculoskeletal Review, was mentioned in an online newsletter from the Food and Drug Administration (FDA).
The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”
It read, in part, “A study evaluating Axiom Worldwide’s DRX9000 true nonsurgical spinal decompression system has produced positive results. … The study chronicled a patient who underwent 22 treatments with the device over a seven-week period and reported significant pain relief at the end of the study.”
Source: Axiom WorldWide, www.axiomworldwide.com
Related Posts
Logan College of Chiropractic offers post-9/11 financial aid to military veterans- Expert COVID-19 panel on virus origins, emergency bill, front-line workers, more
- F4CP commends The Joint Commission for revising standard to include non-pharmacologic methods in care, treatment, and services for pain management
- New tool from OPTP helps relieve myofascial tension
- Chiropractic advocate honored at Northwestern Health Sciences University gala
- Learning The Feldenkrais Method and what it brings to your practice
